Both genetic and environmental factors are of importance for development of Type i (insulin-dependent) diabetes mellitus. This has been demonstrated by a concordance rate of 35-50 % for monozygotic twins [1] . An HLA identical sibling of a Type i diabetic patient carries a 15-25 % risk of developing this disease [2] . These figures demonstrate that genes in the HLA complex are by far the most important in determining genetic predisposition. However, the exact genes in the HLA complex which are involved have not yet been determined.
One reason may be the complexity of the HLA associations in Type i diabetes. Several different HLA genes have been found to be associated with susceptibility or resistance, and often to variable degrees. Another reason is the strong linkage disequilibrium which exists for genes in the HLA complex; i. e. particular allelic variants are often present together on the same HLA chromosomal complex ( = haplotype). A third reason is that Type i diabetes may be a heterogenous disease, where different autoimmune responses may lead to beta-cell destruction.
Recent studies have demonstrated that some HLA-DQ genes are most strongly associated with Type 1 diabetes susceptibility. This was also corroborated in a recent international study [3] . Here we review evidence that particular HLA-DQ molecules as such play a dominant role in determining susceptibility or resistance. We also discuss possible mechanisms behind the direct involvement of particular DQ molecules.
The HLA complex
Some of the HLA gene loci known at present are shown in Figure 1 , but there are many others such as those presented by Trowsdale and Campbell [4] . The class I and II regions contain genes encoding the HLA cell-membrane molecules. They are composed of an o~ and a fl chain heterodimer. The genes encoding the c~ chain of the classic class I molecules A, B and C and those encoding both chains of the class II molecules DR, DQ and DP (Fig. 2 Fig.1 . The HLA gene complex on the short arm of chromosome no. 6 contains many different gene loci. Genes encoding the classic HLA class I and class II cell-membrane molecules (A, B, C, DR, DQ and DP) are marked as filled squares. Genes encoding other molecules are hatched. Genes which are not known to be expressed are marked as open squares with small dots are present in the HLA complex and are very polymorphic (except the DRA gene encoding the DRoc chain). The number of allelic variants known is given in Figure 1 . They are named by a four digit number, preceded by the name of the locus to which they belong; e. g. DRBI*0101 etc. [5] .
The class I and II regions also contain many other genes. In the class II region polymorphic genes involved in processing of protein and transport of peptides from the cytosol to the endoplasmic reticulum i. e. large multifunctional protease (LMP), transporter associated with antigen processing (TAP), as well as others with unknown functions ("really interesting new genes" -RING) are found ( Fig. 1) . Interspaced between the class I and II regions is the class III region containing genes encoding various complement factors, tumour necrosis factor (TNF) etc. [4, 5] .
A typical feature of HLA complex genes is linkage disequilibrium. For example, the A*0101, B*0801, DRBI*0301, DQAI*0501, and DQBI*0201 genes (encoding the A1,B8,DR3 and D Q2 molecules, respectively), which all are associated with Type 1 diabetes susceptibility, are very often found together on the same haplotype.
The classic HLA molecules
The class I molecules A, B and C are present on most cells. In contrast, the class II molecules DR, DQ and DP are mainly present on monocytes, macrophages, dendritic cells and B lymphocytes, but may be induced on many cells by factors such as interferon-7(IFN-7). Since both the o~ and flchain genes of DQ and DP molecules are polymorphic, and since class II molecules may be encoded by o~ and/3 chain genes both in cis position (on the same haplotype) as well as in trans position (on different haplotypes; Fig. 2 ) each individual may potentially express as many as four different variants of DQ or DP molecules or both.
Many HLA molecules have been serotogically defined and are named by a number, preceded by the name of the series to which it belongs (A1,B8,DR3,DQ2 etc.). However, genomic typing of the HLA genes is now more and more becoming the method of choice, particularly for typing of the HLA class II variants. Since more HLA genes have been identified than may be serologically defined, and since DQ and DP molecules are encoded by two polymorphic genes, the HLA molecules are more precisely named in accordance with the genes encoding them. For example, the DQAI*0301 and DQBI*0302 genes encode the DQ molecule DQ((z1*0301,fll*0302), previously called DQ8.
HLA associations in Type 1 diabetes
Susceptibility to develop Type I diabetes was first found associated with the HLA class I molecules B8 and B15, later more strongly with the class II molecules DR3 and DR4 [6] , which are in linkage disequilibrium with B8 and B15, respectively. DR3/DR4 heterozygous individuals were found to be at a particularly high risk of developing Type I diabetes. Weaker associations were detected to DR1, DR6 and DR8 [7] . In contrast, DR2 and to a lesser extent DR5 were rare among Type 1 diabetic patients; i. e. they were associated with resistance [6, 8] . Among Japanese patients, DR4 and DR9 were most prevalent [7] .
More recently, Type i diabetes susceptibility was found to be even more strongly associated with some DQ genes [%12]. For example, only individuals carrying the haplotype DR4-DQ8, and not those being DR4-DQ7, were at an increased risk of developing Type 1 diabetes [13] . Thus, the DR4 association was apparently caused by linkage disequilibrium to DQ8. The particularly high risk in DR3-DQ2/DR4-DQ8 heterozygotes might then be explained by an association to a trans-encoded DQ molecule in these individuals [14] . Todd and co-workers [15] suggested that it was the amino acid present at DQfl chain residue 57 which was of importance; DQ molecules having amino acids other than aspartic acid at this residue (non-Asp) were associated with susceptibility, while those having Asp were associated with dominant resistance. However, more recent studies showed the picture to be more complex [16] , and Japanese Type 1 diabetes patients mostly have DQ)3 chains of Asp type [8, 17] .
Khalil et al. [18] proposed that cis or trans encoded DQ molecules consisting of a DQ(x chain having arginine (Arg) at position 52 and a non-Asp DQflchain were most strongly associated with Type 1 diabetes susceptibility, and that susceptibility correlated quantitatively with the expression of such cis or trans encoded DQ molecules [19] . DQ molecules being DQc~ non-Arg and Daft Asp were supposed to confer protection. However, the relative risk associated with the various Type i diabetes susceptibility DQ molecules varied considerably, and Type 1 diabetic patients are found who have protective DQo~ or DQ]3 chains, or both [20] . This is particularly so among Japanese subjects [8, 17] .
We suggested recently [21] that Type i diabetes susceptibility might be primarily associated with five or six particular cis or trans encoded DQ molecules, which are common for Black and Caucasian subjects, but in part different for Japanese.
Other studies indicated, however, also strong contributions by particular DRB 1 genes encoding given variants of DR4 [22] , or other genes in the HLA complex [23, 24] . One recent study even indicated association to some TAP gene variants [25] . Thus, it could still not be excluded that the primary association in Type 1 diabetes were to some other or unknown genes in the HLA complex, in strong linkage disequilibrium with given DQ genes, or to particular combinations of genes ("extended haplotypes").
Results of a recent international collaborative study
As part of the 11th International Histocompatibility Workshop (1991), 981 unrelated Black, Caucasian or Japanese Type i diabetic patients were genomically typed for HLA class II alleles, and the results compared with those obtained by typing of 2228 healthy control subjects. The results clearly demonstrated that Type 1 diabetes susceptibility was most strongly associated with particular combinations of DQA1 and DaB1 genes in all three ethnic groups [3] . The combinations demonstrating the strongest and most significant associations are listed in Table 1 , together with the corresponding serological DQ and associated DR specificities. DQAI*0301 together with DQBI*0302, and DQAI*0501 together with DQBI*0201, in both cases in cis position, were found associated with Type i diabetes susceptibility in all three ethnic groups. Among Blacks a significant association was also found to DQAI*0301 together with DQBI*0201 in cis position (often together with genes encoding DR7), while among Caucasians and Japanese an association with the same two DQ genes in trans position was seen (Fig. 2) . The Caucasian gerlotype most often involved was DR3-DQ2/DR4-DQ8 (Fig.2) . However, this genotype also carries another pair of DQ genes in trans position; DQAI*0501 and DQBI*0302. Accordingly, a strong association of Type i diabetes susceptibility to this trans combination of DQ genes was also seen among Caucasians (Table 1 ).
In the Japanese Type i diabetic patients susceptibility was also associated with DQAI*0301 together with DAB1*0303, and DQAI*0301 together with DQBI*0401, in both cases in cis position. These haplotypes are very rare in Blacks and Caucasians. However, in Blacks and Caucasians, a weaker but significant association was found with the DQAI*0301 and DAB1*0402 genes in trans position. Interestingly, the DaB 1"0401 and DQBI*0402 genes are very similar, the only known difference being a single nucleotide substitution at codon 23. Thus, this is another example of a Type i diabetes associ- Only significantly decreased in Black and Caucasian subjects. This haplotype is very rare in Japanese subjects ation with the same pair of DQ genes, in cis or trans position (Fig. 2) depending on ethnic group [26] .
Of the investigated Type i diabetic patients, 80-90 % carried one or more of the combinations of DQA1 and DQB1 genes listed in Table 1 . Individuals having more than one of these particular combinations of DQ genes were at an increased risk of developing Type 1 diabetes; i.e. some additive effects of these combinations of DQ genes on susceptibility was observed.
Resistance against development of Type 1 diabetes was found associated with several other combinations of DQA1 and DQB1 genes in cis position (Table 1) . In all three ethnic groups the strongest resistance was found with DQAI*0102 together with DQBI*0602, or with other DQ genes encoding variants of DQ6. Slightly less resistance was associated with D QA1"0501 together with DQBI*0301. The DQ-associated resistance was partly, but not completely dominant over the DQ-associated susceptibility. For example, there was a significant reduction in the frequency of the DQAl*0501-DQBI*0201/DQAI*0102-DQBI~0602 (DQ2/DQ6) genotype among Caucasian Type 1 diabetic patients compared to healthy control subjects, but some few patients carried such combinations of DQ genes.
Particular DQ molecules as such play a dominant role in determining susceptibility or resistance
The strongest evidence for this concept is that in all three ethnic groups Type 1 diabetes susceptibility or resistance is significantly associated with particular combinations of DQA1 and DQB1 genes, sometimes in cis position, in other cases either in cis or trans position (Table 1 ).
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Most important is the susceptibility associated with DQAI*0301 and DQBI*0201 in cis or trans position, since the same DQ molecule, e. g. DQ(~I*0301,fl 1"0201), is encoded in either position of the genes [14, 27] (Fig. 2) . Equally important is the susceptibility associated with DQAI*0301 together with DQBI*0401 or 0402 in cis or trans position, since here functionally identical or very similar DQ molecules, e.g. DQ(cxl*0301,fll*0401) or DQ(cd*0301,fl 1"0402), are being encoded in either position [28] (Fig. 2) . In these two cases, therefore, the evidence strongly indicates that the Type 1 diabetes susceptibility is primarily determined by the corresponding cis or trans encoded DQ molecules themselves. A less likely explanation would be a primary association to a combination of two other genes closely linked to these DQA1 and DQB1 genes in cis or trans position, one being centromeric to DQB1, the other telomeric to DQA1 (Fig. 1 ). Strong association with two genes in cis or trans position also argues against a primary association with given extended HLA haplotypes.
Since in these two cases the corresponding DQ molecules themselves are the best candidates for determining susceptibility, it is likely that the same is true when two DQ genes in cis position are involved.
Is resistance against Type 1 diabetes also determined by particular DQ molecules? Up to now, it has been difficult to ascertain whether resistance is primarily associated with DR2 or DQ6 genes, since the genes involved are often present on the same haplotype. The Workshop studies revealed, however, that the DQAl*0102-DQBl*0602 (DQ6) haplotype associated with resistance might carry different DRB1 genes. Among Blacks this haplotype carried DRBl*1503 or DRBI*ll [29] , while among Caucasians DRB 1 * 1501 was carried on this haplotype. Other recent studies have also indicated that resistance is more strongly associated with DQ6 than DR2 [30, 31] . In Japanese, resistance is associated with the DQAI*0103-DQBI*0601 haplotype, which may carry DRB1 genes encoding either DR2 or DR8 (Table 1) . Therefore, resistance against Type i diabetes also seems to be primarily associated with given DQ molecules, the most important being different variants of very similar DQ6 molecules.
Available evidence thus strongly suggests that some particular DQ molecules determine Type 1 diabetes susceptibility, others determine resistance, while still others are neutral. A varying degree of susceptibility or resistance seems to be conferred by these DQ molecules, whereas DQ molecules which determine resistance are often dominant over those which determine susceptibility. The degree of genetic predisposition for developing Type 1 diabetes carried by an individual would therefore be the result of his or her particular combination of DQ molecules.
This would also explain why the HLA genotype DR3-DQ2/DR4-DQ8 is, in particular, strongly associated with Type 1 diabetes susceptibility, since by this DQ genotype (DQAl*0501-DQBl*0201/DQAl*0301-DQBl*0302) four different DQ molecules determining susceptibility are encoded in cis or trans position (Table 1, Fig. 2) . Similarly, it is possible to explain why a given DQ molecule in some combinations, but not in others may be associated with susceptibility. For example, the Type i diabetes susceptibility DQ molecule encoded by DQAI*0301 and DQBl*0201 in trans position in DR3-DQ2/DR4-DQ8 heterozygotes, is not (or to a lesser degree) associated with Type I diabetes susceptibility when encoded in trans position in DR3-DQ2/DR4-DQ7 or DR4-DQ8/ DR7-DQ2 heterozygotes. However, in the latter two cases this particular trans encoded DQ molecule is found together with DQ molecules associated with resistance. The Workshop studies revealed that the DQ molecules encoded by DQAI*0301 and DQBI*0301 (DQ7) or DQAI*0201 and DQBI*0201 (a variant of DQ2 on the DR7 haplotype) were significantly associated with resistance (data not shown). Another factor may be that DQ genes in the trans posistion do not always lead to expressed DQ molecules, or to DQ molecules expressed to a variable degree. This might depend on the particular combination of DQ genes in cis and trans position in a given genotype [32] .
A primary involvement of the DQ molecules mentioned also explains most previously found DR associations (see above and Table 1 ). However, this does not exclude that other genes in the HLA complex may contribute. In the 11 th Workshop, no associations were found with any DPA1 or DPB1 alleles. However, a contribution by some DRB1 alleles could not be excluded. By studying Type i diabetic patients and HLA-matched control subjects, we were recently unable to confirm the reported association to given TAP gene variants (R0nningen KS, Undiien DE, Ptoski R et al., unpublished data).
It should be noted, however, that 10-20 % of the Type 1 diabetic patients studied in the Workshop did not carry any of the combinations of DQA1 and DQB1 genes listed in Table 1 . It remains to be established whether other DQ molecules may also confer susceptibility, or whether other genes in the HLA complex may determine susceptibility in these cases. Also, some non-HLA genes are known to play a role [33] .
How may HLA-DQ molecules determine Type 1 diabetes susceptibility or resistance?
Since Type i diabetes is probably the end result of a T-cell dependent and probably mainly T-cell mediated autoimmune destruction of islet beta cells [34] , HLA cell-membrane molecules have to be involved. HLA class I molecules bind and present peptide fragments of antigen to the T-cell receptors (TCR) of CD8 § T cells (mainly cytotoxic), while HLA class II molecules have the same function for CD4 + T cells (mainly helper T cells) [35] . The polymorphism of HLA molecules is mainly localized to their peptide-binding clefts [36] . Thus, different variants of HLA molecules differ with respect to the shape etc. of their clefts, which determine which peptides may be bound. Each variant of HLA molecules can only bind one peptide at a time, from a restricted set of peptides [35, 37] . Thus, the HLA molecules carried by a given individual will determine the repertoire of antigenic peptides his or her T cells may be able to recognize.
Since Type 1 diabetes susceptibility seems mainly to be determined by given DQ molecules, CD4 + T cells recognizing given islet beta-cell derived peptides presented by some DQ molecules may be instrumental in the immunopathogenic process, at least initially. How are such self-reactive T cells allowed to develop, and how do they become activated?
During their thymic development T cells are both positively and negatively selected, depending on the TCR they express. T cells with TCR for self-peptide/HLA complexes are first positively selected, then T cells with high affinity TCR for such self-peptide/HLA complexes are negatively selected or deleted. The details of this process are not fully known [38] , but the result will be a set of mature T cells mainly able to recognize various peptides derived from foreign proteins in the cleft of self-HLA molecules.
However, negative selection is probably leaky. T cells with TCR for some seIf-peptides may escape negative selection because the concentration of some self-peptides in the thymus is too low. This may be the case for some potential beta-cell reactive CD4 + T cells. Such T cells may, however, be inactivated (anergized) upon confrontation with islet beta cells, due to the inability of beta cells to provide certain co-stimulatory signals necessary for T-celt activation [39] . Alternatively, the lack of co-stirnulatory signals will cause T-cell ignorance; i.e. the T cells will be neither anergized nor activated [40] . In any case, most escaped potential self-reactive T cells may not cause autoimmune disease because they are normally not activated. The situation will be entirely different, however, should some beta-cell derived peptides be presented in sufficient concentration by professional antigen presenting cells (APC) able to deliver the necessary co-stimulatory signals. Animal experiments have shown that T cells with TCR for virally-derived peptides inserted by transfection in pancreatic beta cells, will normally be ignorant and not cause beta-cell destruction. However, following infection with the corresponding virus, and thus presentation of the virally-derived peptides by professional APC, the T cells may become activated and cause beta-cell destruction [40] . This points to a possible mechanism of Type 1 diabetes (and other autoimmune diseases).
Environmental factors are known to be important for the development of Type 1 diabetes. The nature of such factors is unknown, but certain viruses have been suspected for a long time [41] . Possibly, degradation of some viral proteins may result in peptides showing molecular mimicIT to certain beta-cell derived peptides. Following a virus infection, when such viral peptides are presented by professional APC, anergized or ignorant CD4 + T cells with TCR for the corresponding beta-cell derived peptides may then become activated. Another environmental factor could be cows milk. Children with Type 1 diabetes often have antibodies to a particular peptide derived from bovine serum albumin, antibodies which also react with a pancreatic beta-cell surface protein (p69) that is inducible with IFN-7 [42] . If ignorant T cells with TCR for p69 derived peptides exist, they may become activated by confrontation with the bovine serum albumin derived peptide presented by professional APC. Should a viral infection later occur in the vicinity of islet beta cells, IFN-~/may induce expression of p69, and thus become a target for T-cell attack.
How and where do the involved DQ molecules exert their effects in these processes? Intra-thymically, the DQ molecules associated with susceptibility may cause positive selection of potentially beta-cell reactive CD4 + T cells. In contrast, DQ molecules associated with resistance may cause positive selection of some regulatory or protective T cells, or deletion of potential beta-cell reactive T cells (as discussed by MOiler et al. [43] ).
We consider it more likely that the DQ molecules associated with susceptibility exert their effects extra-thymically. They may preferentially bind and present the peptides involved, both putative triggering peptides and the target beta-cell derived peptides. If DQ molecules are induced by IFN-Tand TNF [44] in islet beta cells as a result of infection, the activated CD4 + T cells may directly destroy the beta cells. Alternatively, they may recruit CD8 § T cells, macrophages or initiate antibody production.
Since Type i diabetes is associated with several different DQ molecules, several different beta-cell derived peptides may be involved. Thus, Type 1 diabetes may be a heterogenous disease with respect to the fine specificity of the beta-cell reactive T cells. Alternatively, only one betacell derived peptide is potentially immunopathogenic, which may bind (with different affinity) to all DQ molecules associated with susceptibility. In any case the presence of several different DQ molecules associated with susceptibility may increase the chance of recognition by potential beta-cell reactive T cells. This may explain the additive effects on susceptibility of having more than one of these DQ molecules.
Resistance against Type 1 diabetes by given DQ molecules is more difficult to explain by extra-thymic mechanisms. Nepom [45] has suggested that HLA molecules associated with resistance may tightly bind potential diabetogenic peptides, thus competing with binding of the same peptides to the DQ molecules involved in susceptibility. This mechanism of resistance would, however, require that T cells able to recognize such diabetogenic peptides bound to DQ molecules associated with resistance (e.g. DQ6) should be inhibited or not be allowed to develop.
Conclusion
The HLA-associated susceptibility or resistance to develop Type 1 diabetes seems mainly to be determined by particular HLA-DQ molecules, A direct contribution by other genes in the HLA complex cannot be excluded, and particular DQ molecules may not determine genetic susceptibility in all cases of Type 1 diabetes. The DQ molecules involved may exert their effects intra-thymically during T-cell development and differentiation, or extrathymically by preferential peptide presentation to potential beta-cell reactive T cells. The finding that certain DQ molecules may determine Type 1 diabetes susceptibility may lead to new methods such as the use of blocking pep-E. Thorsby and K. S. Rcnningen: HLA associations in Type 1 diabetes tide analogues for preventing the development of Type 1 diabetes in susceptible individuals.
